Louisiana State Employees Retirement System Takes Position in Progyny, Inc. (NASDAQ:PGNY)

Louisiana State Employees Retirement System acquired a new stake in Progyny, Inc. (NASDAQ:PGNY) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 23,400 shares of the company’s stock, valued at approximately $870,000.

Other large investors have also made changes to their positions in the company. RiverPark Advisors LLC boosted its holdings in shares of Progyny by 54.0% in the 4th quarter. RiverPark Advisors LLC now owns 1,067 shares of the company’s stock valued at $40,000 after acquiring an additional 374 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Progyny during the third quarter worth $53,000. CWM LLC boosted its holdings in Progyny by 16.1% during the third quarter. CWM LLC now owns 3,490 shares of the company’s stock worth $119,000 after buying an additional 483 shares in the last quarter. Duality Advisers LP purchased a new stake in Progyny during the third quarter worth $202,000. Finally, Olympiad Research LP purchased a new stake in Progyny during the third quarter worth $222,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Chairman David J. Schlanger sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $38.50, for a total transaction of $770,000.00. Following the completion of the sale, the chairman now directly owns 86,312 shares in the company, valued at $3,323,012. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CFO Mark S. Livingston sold 11,165 shares of the firm’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $37.62, for a total transaction of $420,027.30. Following the completion of the sale, the chief financial officer now directly owns 50,119 shares in the company, valued at $1,885,476.78. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman David J. Schlanger sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $38.50, for a total transaction of $770,000.00. Following the sale, the chairman now owns 86,312 shares of the company’s stock, valued at $3,323,012. The disclosure for this sale can be found here. Insiders sold 120,515 shares of company stock worth $4,570,131 over the last three months. Insiders own 12.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on PGNY shares. Truist Financial reissued a “buy” rating and set a $46.00 price target on shares of Progyny in a report on Wednesday, April 17th. SVB Leerink assumed coverage on shares of Progyny in a report on Monday, February 26th. They set an “outperform” rating and a $49.00 price target on the stock. KeyCorp decreased their price objective on shares of Progyny from $45.00 to $43.00 and set an “overweight” rating on the stock in a report on Wednesday, February 28th. Barclays assumed coverage on shares of Progyny in a report on Wednesday, January 3rd. They set an “overweight” rating and a $48.00 price objective on the stock. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of Progyny in a report on Monday, February 26th. Ten research analysts have rated the stock with a buy rating, According to MarketBeat.com, Progyny currently has a consensus rating of “Buy” and a consensus price target of $48.30.

Progyny Stock Down 0.3 %

Shares of NASDAQ PGNY opened at $32.50 on Friday. The firm has a 50-day simple moving average of $36.02 and a 200-day simple moving average of $35.63. The stock has a market capitalization of $3.12 billion, a price-to-earnings ratio of 52.42, a price-to-earnings-growth ratio of 1.34 and a beta of 1.48. Progyny, Inc. has a 52 week low of $29.44 and a 52 week high of $44.95.

Progyny (NASDAQ:PGNY) last issued its earnings results on Tuesday, February 27th. The company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.04. The business had revenue of $269.94 million during the quarter, compared to analysts’ expectations of $274.08 million. Progyny had a net margin of 5.70% and a return on equity of 12.64%. The company’s quarterly revenue was up 26.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.03 earnings per share. As a group, equities research analysts expect that Progyny, Inc. will post 0.7 EPS for the current year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.